The online version of the original chapter can be found at http://dx.doi.org/10.1007/978-1-4471-5251-4_6
You have full access to this open access chapter, Download chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Treatment of Neurological Disorders
Page 305, “Migraine (moderate pain during attack)”:
Tablets, e.g., zolmitriptan (see zolmitriptan tablets); sumatriptan 50 mg or 100 mg, max. 200–300 mg/24 h; and almotriptan 12.5 mg, max. 25 mg/24 h
(Instead of: “Tablets, e.g., zolmitriptan (see zolmitriptan tablets); sumatriptan 50 mg or 100 mg, max. 200–300 mg/24 h; and almotriptan 2.5 mg or 5 mg; for second dose wait 2 h, max. 10 mg/24 h”)
Page 306, “Migraine (preventive treatment)”:
Beta-blockers, e.g., metoprolol 100 mg once or twice daily or 200 mg once daily, and propranolol 20–80 mg once or twice daily
(Instead of: “Beta-blockers, e.g., metoprolol 100–200 mg once or twice daily and propranolol 20–80 mg once or twice daily)
Page 306, “Cluster headache, transitional treatment”:
Ergotamine 1–2 mg, p.o. or as a suppository once or twice daily
(Instead of: “Dihydroergotamine 1–2 mg, p.o. or as a suppository once or twice daily, may be given parenterally as well”)
Page 337, “Treatment of nonmotor symptoms, Hypotension”:
Dihydroergotamine 2.5 mg or 5 mg twice daily
(Instead of: “Ergotamine 5 mg three times daily”)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Kondziella, D., Waldemar, G. (2014). Erratum Chapter 6 Treatment of Neurological Disorders. In: Neurology at the Bedside. Springer, London. https://doi.org/10.1007/978-1-4471-5251-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5251-4_7
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5250-7
Online ISBN: 978-1-4471-5251-4
eBook Packages: MedicineMedicine (R0)